
Immunology Featured Research
Immunity depends upon the regulated recombination of variable (V), diversity (D), and joining (J) gene-segments at B cell receptor (BCR) and T cell receptor (TCR) loci to generate sufficient receptor diversity to enable recognition of a near-limitless array of potential antigens.
Read More
The Department of Pathology has a proud tradition of basic and clinically oriented investigation that dates back to our inception in 1881, when the Department was established to study "the pathology of many diseases." Since then, pathology researchers at NYU have continuously set the pace for innovative research.
Our 45 research faculty work in diverse areas, ranging from fundamental aspects of cell and molecular biology to clinical trials. These faculty are loosely organized into three broadly defined research programs: Experimental Pathology, Immunology, and Molecular Oncology, which generally correspond to our graduate training programs in Pathobiology and Molecular Oncology and Immunology.
We have augmented our already diverse group of researchers by recruiting five new faculty members from premier research institutions to the Department since 2004, all of whom already have significant research funding. Research in the Department is well-funded, with over $25 million in overall funding for the fiscal year 2007, and we consistently rank in the top 20 Pathology programs nationwide in terms of NIH funding. We currently enjoy over 33,000 square feet of new or newly renovated laboratory space, and expect to recruit additional research faculty over the years ahead. Most importantly, our faculty consists of many collaborative, collegial and scholarly researchers who thrive on stimulating intellectual challenges and who enjoy mentoring the next generation of scientists and physician-scientists.